Home Newsfeeds Winmark Q3 Sales $21.16M Up From $20.15M YoY

Winmark Q3 Sales $21.16M Up From $20.15M YoY

Winmark (NASDAQ:WINA) reported $21.16 million in sales this quarter. This is a 5.02 percent increase over sales of $20.15 million the same period last year.

byBenzinga Newsdesk

October 12, 2022

1 minute read

Winmark (NASDAQ:WINA) reported $21.16 million in sales this quarter. This is a 5.02 percent increase over sales of $20.15 million the same period last year.

UK Car Production Falls 10% In 2022; EVs See Strong Performance

By Shivani Kumaresan

January 26, 9:48 AM

Annual U.K. car production fell 9.8% to 775,014 units in 2022 as global chip shortages, and structural changes depress output.

HMC

Occidental’s CrownRock Deal Delayed But Sees Permian Basin Production Boost

By Lekha Gupta

May 9, 6:11 AM

Occidental Petroleum Corporation ) expects to close acquisition of CrownRock LP in Q3 FY24. CEO anticipates no hurdles from regulators.

FTXN

President Emmanuel Macron Blames Social Media And ‘Intoxicating’ Video Games For French Youth Riots

By Franca Quarneti

July 3, 3:22 PM

Emmanuel Macron, the president of France, has pointed to video games and social media as contributing factors to the widespread escalation of riots across his country.

SNAP

Aprea Therapeutics Announces Presentations On Its Next Generation WEE1 Inhibitor, APR-1051, And A Novel Macrocyclic ATR Inhibitor, ATRN-119, At AACR Annual Meeting 2024

By Benzinga Newsdesk

April 10, 12:02 PM

Pre-clinical findings underscore the potential of APR-1051, a next-generation WEE1 kinase inhibitor, to be a well-tolerated and effective treatment for Cyclin E-overexpressing cancers IND for APR-1051 has been

APRE

Winmark Q3 Sales $21.16M Up From $20.15M YoY

Related Posts

UK Car Production Falls 10% In 2022; EVs See Strong Performance

Occidental’s CrownRock Deal Delayed But Sees Permian Basin Production Boost

President Emmanuel Macron Blames Social Media And ‘Intoxicating’ Video Games For French Youth Riots

Aprea Therapeutics Announces Presentations On Its Next Generation WEE1 Inhibitor, APR-1051, And A Novel Macrocyclic ATR Inhibitor, ATRN-119, At AACR Annual Meeting 2024